Welcome to our dedicated page for Marsh & Mclennan SEC filings (Ticker: MRSH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Marsh (NYSE: MRSH) SEC filings page on Stock Titan is designed to help investors and analysts review the company’s regulatory disclosures in a structured way. While recent SEC filings are not listed in the available data, this page is where users can access Marsh’s future submissions to the US Securities and Exchange Commission once they are posted to EDGAR.
For a company that describes itself as a global leader in risk, reinsurance and capital, people and investments, and management consulting, key filings such as annual reports on Form 10-K and quarterly reports on Form 10-Q can provide important detail on business segments, risk factors, and financial performance. Current reports on Form 8-K may highlight material events, including dividend declarations or other board decisions affecting Marsh’s common stock.
When available, proxy statements and related filings can offer additional information on governance and executive matters, while Form 4 filings can be used to track transactions by directors and certain officers in Marsh’s equity.
Stock Titan enhances these documents with AI-powered summaries that explain the main points of lengthy filings in accessible language. Users can quickly see what has changed from one period to the next, identify notable disclosures, and then drill into the full text for deeper analysis. Real-time updates from EDGAR ensure that new Marsh filings appear promptly, while AI-generated insights help reduce the time required to interpret complex regulatory documents.
Lute Jane H reported acquisition or exercise transactions in this Form 4 filing.
Marsh & McLennan Companies director Jane H. Lute reported routine equity compensation activity. She received 169.29 restricted stock units under the Directors Stock Compensation Plan at a reference price of $160.60 per unit. An additional 41.2 units were credited as dividend equivalents, all convertible into common stock on a 1-for-1 basis.
Lute Jane H reported acquisition or exercise transactions in this Form 4 filing.
Marsh & McLennan Companies director Jane H. Lute reported routine equity compensation activity. She received 169.29 restricted stock units under the Directors Stock Compensation Plan at a reference price of $160.60 per unit. An additional 41.2 units were credited as dividend equivalents, all convertible into common stock on a 1-for-1 basis.
Marsh & McLennan director Jan Siegmund reported an internal equity adjustment involving 5.29 restricted stock units credited as dividend equivalents under the Directors Stock Compensation Plan. These units convert to common stock on a 1‑for‑1 basis, increasing his restricted stock unit holdings to 948.42.
Marsh & McLennan director Jan Siegmund reported an internal equity adjustment involving 5.29 restricted stock units credited as dividend equivalents under the Directors Stock Compensation Plan. These units convert to common stock on a 1‑for‑1 basis, increasing his restricted stock unit holdings to 948.42.
MILLS STEVEN A reported acquisition or exercise transactions in this Form 4 filing.
MARSH & MCLENNAN COMPANIES, INC. director Steven A. Mills received an award of 264 shares of common stock at $160.60 per share as part of his director fees under the company’s Directors Stock Compensation Plan. Following this grant, he holds 4,408.75 shares directly and 47,553 shares indirectly through a trust.
MILLS STEVEN A reported acquisition or exercise transactions in this Form 4 filing.
MARSH & MCLENNAN COMPANIES, INC. director Steven A. Mills received an award of 264 shares of common stock at $160.60 per share as part of his director fees under the company’s Directors Stock Compensation Plan. Following this grant, he holds 4,408.75 shares directly and 47,553 shares indirectly through a trust.
MARSH & MCLENNAN COMPANIES director Anthony Anderson reported an internal adjustment involving 87.67 restricted stock units under the Directors Stock Compensation Plan. These units were credited as dividend equivalents and each converts into one share of common stock. Following this routine plan transaction, Anderson holds 15,732.33 units directly.
MARSH & MCLENNAN COMPANIES director Anthony Anderson reported an internal adjustment involving 87.67 restricted stock units under the Directors Stock Compensation Plan. These units were credited as dividend equivalents and each converts into one share of common stock. Following this routine plan transaction, Anderson holds 15,732.33 units directly.
Marsh & McLennan Companies reported that Dean Michael Klisura, President & CEO of Guy Carpenter, received a grant of 14,907 restricted stock units. Each unit converts into one share of Marsh & McLennan common stock on a 1-for-1 basis.
The restricted stock units vest in three equal annual installments on May 15, 2027, May 15, 2028 and May 15, 2029. Following this award, Klisura is reported as directly holding 14,907 restricted stock units tied to common stock.
Marsh & McLennan Companies reported that Dean Michael Klisura, President & CEO of Guy Carpenter, received a grant of 14,907 restricted stock units. Each unit converts into one share of Marsh & McLennan common stock on a 1-for-1 basis.
The restricted stock units vest in three equal annual installments on May 15, 2027, May 15, 2028 and May 15, 2029. Following this award, Klisura is reported as directly holding 14,907 restricted stock units tied to common stock.
Marsh & McLennan Companies Chief Marketing Officer John Jude Jones received a grant of 5,963 restricted stock units as equity compensation. Each unit converts into one share of common stock. These RSUs vest in three equal annual installments on May 15, 2027, 2028 and 2029, leaving him with 5,963 units reported after this grant.
Marsh & McLennan Companies Chief Marketing Officer John Jude Jones received a grant of 5,963 restricted stock units as equity compensation. Each unit converts into one share of common stock. These RSUs vest in three equal annual installments on May 15, 2027, 2028 and 2029, leaving him with 5,963 units reported after this grant.
Beswick Paul reported acquisition or exercise transactions in this Form 4 filing.
Marsh & McLennan Companies reported that SVP and Chief Information Officer Paul Beswick received a grant of 14,907 restricted stock units. These RSUs represent future rights to receive an equal number of Marsh & McLennan common shares on a 1-for-1 basis.
The restricted stock units vest in three equal annual installments on May 15, 2027, May 15, 2028, and May 15, 2029, encouraging longer-term alignment between the executive and shareholders. All 14,907 RSUs are reported as directly owned following this grant.
Beswick Paul reported acquisition or exercise transactions in this Form 4 filing.
Marsh & McLennan Companies reported that SVP and Chief Information Officer Paul Beswick received a grant of 14,907 restricted stock units. These RSUs represent future rights to receive an equal number of Marsh & McLennan common shares on a 1-for-1 basis.
The restricted stock units vest in three equal annual installments on May 15, 2027, May 15, 2028, and May 15, 2029, encouraging longer-term alignment between the executive and shareholders. All 14,907 RSUs are reported as directly owned following this grant.
South Martin reported acquisition or exercise transactions in this Form 4 filing.
Marsh & McLennan Companies’ Chief Client Officer South Martin received a grant of 5,963 restricted stock units. These units represent the right to receive an equal number of Marsh & McLennan common shares on a 1-for-1 basis, subject to vesting conditions.
The restricted stock units vest in three equal annual installments on May 15, 2027, May 15, 2028, and May 15, 2029. This is a compensation-related award rather than an open-market stock purchase or sale, and after this grant Martin holds 5,963 restricted stock units directly.
South Martin reported acquisition or exercise transactions in this Form 4 filing.
Marsh & McLennan Companies’ Chief Client Officer South Martin received a grant of 5,963 restricted stock units. These units represent the right to receive an equal number of Marsh & McLennan common shares on a 1-for-1 basis, subject to vesting conditions.
The restricted stock units vest in three equal annual installments on May 15, 2027, May 15, 2028, and May 15, 2029. This is a compensation-related award rather than an open-market stock purchase or sale, and after this grant Martin holds 5,963 restricted stock units directly.
MCGIVNEY MARK C reported acquisition or exercise transactions in this Form 4 filing.
Marsh & McLennan Companies executive Mark C. McGivney received a grant of 59,627 restricted stock units. These units were awarded as compensation and are convertible into an equal number of Marsh & McLennan common shares on a 1-for-1 basis.
The restricted stock units vest in three equal annual installments on May 15, 2027, 2028, and 2029, subject to continued service and any plan terms. Following this grant, McGivney holds 59,627 restricted stock units directly, with no open-market buying or selling reported in this filing.
MCGIVNEY MARK C reported acquisition or exercise transactions in this Form 4 filing.
Marsh & McLennan Companies executive Mark C. McGivney received a grant of 59,627 restricted stock units. These units were awarded as compensation and are convertible into an equal number of Marsh & McLennan common shares on a 1-for-1 basis.
The restricted stock units vest in three equal annual installments on May 15, 2027, 2028, and 2029, subject to continued service and any plan terms. Following this grant, McGivney holds 59,627 restricted stock units directly, with no open-market buying or selling reported in this filing.
MARSH & MCLENNAN COMPANIES, INC. reported that executive Nicholas Mark Studer, President and CEO of Marsh Risk, received a grant of 8,945 restricted stock units (RSUs) on Marsh & McLennan common stock as equity-based compensation.
The RSUs convert into common stock on a 1-for-1 basis and are scheduled to vest in three equal annual installments on May 15, 2027, 2028 and 2029. Following this award, Studer holds a total of 14,711 RSUs directly. This is a compensation-related grant, not an open-market share purchase or sale.
MARSH & MCLENNAN COMPANIES, INC. reported that executive Nicholas Mark Studer, President and CEO of Marsh Risk, received a grant of 8,945 restricted stock units (RSUs) on Marsh & McLennan common stock as equity-based compensation.
The RSUs convert into common stock on a 1-for-1 basis and are scheduled to vest in three equal annual installments on May 15, 2027, 2028 and 2029. Following this award, Studer holds a total of 14,711 RSUs directly. This is a compensation-related grant, not an open-market share purchase or sale.